Cargando…
Intravenous methylprednisolone or immunoglobulin for anti-glutamic acid decarboxylase 65 antibody autoimmune encephalitis: which is better?
BACKGROUND: Patients positive for anti-glutamic acid decarboxylase 65 (GAD65) antibodies have attracted increasing attention. Their clinical manifestations are highly heterogeneous and can be comorbid with tumors. Currently, there is no consensus on the therapeutic regimen for anti-GAD65-associated...
Autores principales: | Li, Tao-Ran, Zhang, Yu-Di, Wang, Qun, Shao, Xiao-Qiu, Li, Zhi-Mei, Lv, Rui-Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106675/ https://www.ncbi.nlm.nih.gov/pubmed/32228575 http://dx.doi.org/10.1186/s12868-020-00561-9 |
Ejemplares similares
-
Treatment of Anti-GAD65 Autoimmune Encephalitis With Methylprednisolone
por: Azizi, Shayan, et al.
Publicado: (2021) -
Glutamic acid decarboxylase 65-positive autoimmune encephalitis presenting with gelastic seizure, responsive to steroid: A case report
por: Yang, Camerdy Yue, et al.
Publicado: (2021) -
Anti-Glutamic Acid Decarboxylase (GAD) 65 Encephalitis Mistaken for Herpes Encephalitis and Hashimoto’s Encephalitis (HE): A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023) -
The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
por: Lee, Soon‐Tae, et al.
Publicado: (2022) -
Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series
por: Ren, Changhong, et al.
Publicado: (2021)